tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Samuel Brodovsky, 26 are a BUY (68.42%), 12 are a HOLD (31.58%).
Analyst Samuel Brodovsky, currently employed at TRUIST, carries an average stock price target met ratio of 73.53% that have a potential upside of 22.13% achieved within 77 days.
Samuel Brodovsky’s has documented 71 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VCEL, Vericel Corp Ord at 17-Dec-2024.
Analyst best performing recommendations are on SIBN (SI-BONE).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) at 1/31/2023. The price target of $29 was fulfilled within 2 days with a profit of $1.53 (5.57%) receiving and performance score of 27.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$23
$6.7 (41.10%)
$39
5 days ago
(09-Oct-2025)
5/10 (50%)
$6.7 (41.10%)
106
Buy
$25
$8.7 (53.37%)
$50
5 days ago
(09-Oct-2025)
2/13 (15.38%)
$8.7 (53.37%)
58
Buy
$20
$3.7 (22.70%)
$32
5 days ago
(09-Oct-2025)
6/8 (75%)
$3.7 (22.70%)
89
Buy
$22
$5.7 (34.97%)
$30
5 days ago
(09-Oct-2025)
19/25 (76%)
$5.7 (34.97%)
102
Buy
$42
$25.7 (157.67%)
$42
5 months 7 days ago
(07-May-2025)
6/20 (30%)
$18.92 (81.98%)
172
What Year was the first public recommendation made by Samuel Brodovsky?
